Insider Selling: Christopher Holden Sells 5,000 Shares of Amsurg Corp. Stock (AMSG)
Amsurg Corp. (NASDAQ:AMSG) CEO Christopher Holden unloaded 5,000 shares of the stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $37.56, for a total transaction of $187,800.00. Following the completion of the transaction, the chief executive officer now directly owns 277,889 shares in the company. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
A number of research firms have recently commented on AMSG. Analysts at Cantor Fitzgerald raised their price target on shares of Amsurg Corp. (NASDAQ:AMSG) from $31.00 to $37.00 in a research note to investors on Friday, July 26th. They now have a “hold” rating on the stock. Separately, analysts at Piper Jaffray Cos. raised their price target on shares of Amsurg Corp. (NASDAQ:AMSG) from $32.00 to $36.00 in a research note to investors on Thursday, July 25th. They now have a “neutral” rating on the stock. Finally, analysts at Zacks reiterated a “neutral” rating on shares of Amsurg Corp. (NASDAQ:AMSG) in a research note to investors on Wednesday, July 17th. They now have a $41.00 price target on the stock.
Amsurg Corp. (NASDAQ:AMSG) traded up 1.21% during mid-day trading on Wednesday, hitting $38.59. 68,916 shares of the company’s stock traded hands. Amsurg Corp. has a 52-week low of $25.00 and a 52-week high of $41.00. The stock’s 50-day moving average is $39.06 and its 200-day moving average is $35.61. The company has a market cap of $1.247 billion and a price-to-earnings ratio of 17.64.
Amsurg Corp. (NASDAQ:AMSG) last issued its quarterly earnings data on Tuesday, July 23rd. The company reported $0.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.56 by $0.02. The company had revenue of $269.30 million for the quarter, compared to the consensus estimate of $265.84 million. During the same quarter in the previous year, the company posted $0.51 earnings per share. The company’s revenue for the quarter was up 16.9% on a year-over-year basis. On average, analysts predict that Amsurg Corp. will post $2.20 earnings per share for the current fiscal year.
AmSurg Corp. is the owner and operator of short stay ambulatory surgery centers (NASDAQ:AMSG) in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.